, Tracking Stock Market Picks
Enter Symbol:
Myriad Genetics, Inc. (MYGN) [hlAlert]

up 29.89 %

Myriad Genetics, Inc. (MYGN) rated Buy with price target $31 by WallachBeth

Posted on: Monday,  Oct 1, 2012  8:25 AM ET by WallachBeth

WallachBeth rated Buy Myriad Genetics, Inc. (NASDAQ: MYGN) on 10/01/2012, when the stock price was $27.30. Since
then, Myriad Genetics, Inc. has gained 29.89% as of 01/21/2016's recent price of $35.46.
If you would have followed this WallachBeth's recommendation on MYGN, you would have gained 29.89% of your investment in 1207 days.

Myriad Genetics, Inc. uses gene-based medicine to develop therapeutic and molecular diagnostic products. They employ a variety of proprietary proteomic technologies to discover disease genes and to understand the role these genes and their related proteins play in the onset and progression of disease. They have integrated these technologies using bioinformatics and robotics systems to conduct their research efforts on a high-throughput basis. This has enabled them to identify numerous proteins as targets for new drugs and molecular diagnostic tests.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2012 8:25 AM Buy
27.30 31.00
as of 12/31/2012
1 Week up  0.03 %
1 Month down  -5.11 %
3 Months down  -0.18 %
1 YTD down  -0.18 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy